Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Inclusion Criteria: * Outpatients aged 2 to \< 18 years with severe AD (score 8 or 9 according to Rajka and Langeland) * responded to 21 days of treatment with prednicarbate cream 0.25% during screening phase Exclusion Criteria: * Patients who had received phototherapy, systemic or topical therapy or systemic corticosteroids shortly prior to study